If you are not happy with the results below please do another search
Swiss drugmaker Roche plans to boost rapid Covid-19 antigen test production to hundreds of millions monthly – including possible saliva tests – Chief Executive Severin Schwan said, acknowledging the fierceness of the pandemic’s second wave took him by surprise.
W2O announced two new products available through Symplur, the company’s social media analytics platform dedicated exclusively to the healthcare industry.
Moderna Inc. is on track to report early data from a late-stage trial of the company’s Covid-19 vaccine candidate in November, offering the clearest timeline yet on when the world will know whether the vaccine is effective.
Cerevel Therapeutics began trading on the Nasdaq.
Gilead Sciences Inc. cut the company’s 2020 revenue forecast, citing lower-than-expected demand and difficulty in predicting sales of remdesivir, the only treatment approved in the United States for patients hospitalized with Covid-19.
Shionogi & Co. is planning clinical trials by year-end 2020 for what may be one of Japan’s first domestically produced Covid-19 vaccines to reach the market, as the globe races to secure enough doses to battle the pandemic.
Amgen Inc. reported that third-quarter 2020 adjusted profit rose 17% due to stronger sales of drugs such as the osteoporosis treatment Prolia and the psoriasis medication Otezla, bucking challenges from lower drug prices and Covid-19.
Regeneron Pharmaceuticals Inc.’s coronavirus antibody cocktail – the experimental treatment that U.S. President Donald Trump received – significantly reduced medical visits in a trial of nearly 800 patients with mild-to-moderate Covid-19.
Find out which biopharma companies are raking in the cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
A roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines includes the use of miniature lungs and colons to help test Covid-19 treatments.